Incannex Healthcare (IXHL) Net Equity Issued and Repurchased (2023 - 2026)

Incannex Healthcare (IXHL) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.5 million (changed N/A YoY) and the FY2025 annual result came in at $48.3 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased advanced to $7.0 million in Q1 2026 per IXHL's latest filing, from $2.2 million in the prior quarter.
• Over the last five years, Net Equity Issued and Repurchased for IXHL reached as high as $69.5 million in Q3 2025 and fell as low as -$73000.0 in Q1 2023.
• A 3-year average of $19.1 million and a median of $4.6 million in 2025 frame the typical range for Net Equity Issued and Repurchased.